Trademark: 87229065
Status Date
Tuesday, June 30, 2020
Filing Date
Monday, November 7, 2016
Published for Opposition
Tuesday, April 25, 2017
Abandoned Date
Tuesday, June 30, 2020
5 Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body
Jun 30, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 30, 2020
Abandonment - No Use Statement Filed
Dec 6, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 5, 2019
Extension 5 Granted
Dec 3, 2019
Extension 5 Filed
Dec 5, 2019
Case Assigned To Intent To Use Paralegal
Dec 3, 2019
Teas Extension Received
Mar 19, 2019
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2019
Extension 4 Granted
Mar 15, 2019
Extension 4 Filed
Mar 15, 2019
Teas Extension Received
Nov 3, 2018
Notice Of Approval Of Extension Request E-Mailed
Nov 1, 2018
Extension 3 Granted
Nov 1, 2018
Extension 3 Filed
Nov 1, 2018
Teas Extension Received
Jun 13, 2018
Notice Of Approval Of Extension Request E-Mailed
Jun 11, 2018
Extension 2 Granted
Jun 11, 2018
Extension 2 Filed
Jun 11, 2018
Teas Extension Received
Oct 31, 2017
Notice Of Approval Of Extension Request E-Mailed
Oct 27, 2017
Extension 1 Granted
Oct 27, 2017
Extension 1 Filed
Oct 27, 2017
Teas Extension Received
Jun 21, 2017
Noa E-Mailed - Sou Required From Applicant
Apr 25, 2017
Official Gazette Publication Confirmation E-Mailed
Apr 25, 2017
Published For Opposition
Apr 5, 2017
Notification Of Notice Of Publication E-Mailed
Mar 17, 2017
Law Office Publication Review Completed
Mar 2, 2017
Approved For Pub - Principal Register
Mar 1, 2017
Teas/Email Correspondence Entered
Mar 1, 2017
Correspondence Received In Law Office
Feb 20, 2017
Assigned To Lie
Feb 7, 2017
Teas Response To Office Action Received
Feb 7, 2017
Notification Of Non-Final Action E-Mailed
Feb 7, 2017
Non-Final Action E-Mailed
Feb 7, 2017
Non-Final Action Written
Feb 7, 2017
Previous Allowance Count Withdrawn
Feb 7, 2017
Withdrawn From Pub - Examining Attorney Request
Jan 22, 2017
Approved For Pub - Principal Register
Dec 31, 2016
Teas/Email Correspondence Entered
Dec 30, 2016
Correspondence Received In Law Office
Dec 30, 2016
Teas Response To Suspension Inquiry Received
Dec 22, 2016
Notification Of Letter Of Suspension E-Mailed
Dec 22, 2016
Letter Of Suspension E-Mailed
Dec 22, 2016
Suspension Letter Written
Dec 21, 2016
Assigned To Examiner
Nov 10, 2016
New Application Office Supplied Data Entered In Tram
Nov 10, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
